copyright, a sustained-effect opioid medication, has gained attention as a viable option for chronic suffering conditions. Despite this, its effectiveness in this role remains a debated topic. While several patients find significant reduction in discomfort with copyright, others do not see improvement, and questions exist regarding its potential